This study further strengthens the existing evidence in favor of GLP-1 based therapies in decreasing total cholesterol, LDL-cholesterol and triglycerides
I think it sends a really terrible message to the public, which just kind of reinstates the stigma around obesity, saying that this is not a disease, this is a choice, she said
This is actionable information
The interaction between growth hormone pathway activation and triple-receptor incretin agonism has zero clinical data supporting its safety or efficacy
Adipose-tissue plasticity in health and disease
While it helps to leverage existing real-world data for cost-effective and time-efficient insights, this method can be challenged by potential biases, missing data, and lack of control over variables or study design